2021-11-15T09:26:39-06:00 2020-12-31 521446779 JOHNSON LAMBERT LLP 4242 SIX FORKS ROAD SUITE 1500 RALEIGH NC 27609 990 2020-01-01 030466352 THE GOG FOUNDATION INC GOGF 4107217126 3168 BRAVERTON ST NO 280 EDGEWATER MD 21037 MARY C SHARP CHIEF FINANCIAL OFFICER 4107217126 2021-11-12 1 MARY SHARP XXX-XX-XXXX J CALVIN MARKS P01226973 9197196400 2 AAL1 IAL1 2020 2022-09-23 18:48:47Z LARRY J COPELAND MD 3168 BRAVERTON ST NO 280 EDGEWATER MD 21037 95256603 0 X WWW.GOG.ORG X 2002 DC THE GOG FOUNDATION'S PRIMARY EXEMPT PURPOSE IS TO PROMOTE EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES. 11 10 41 11 4013 0 2990743 3264417 42494633 44774881 2059695 3089564 48680 4954 47593751 51133816 0 543825 0 0 4476001 5860539 1200 0 334919 32481137 43957850 36958338 50362214 10635413 771602 83724373 96851330 11576502 20361748 72147871 76489582 X THE GOG FOUNDATION, INC. (GOG FOUNDATION) IS A NONPROFIT ORGANIZATION WITH THE PURPOSE OF PROMOTING EXCELLENCE IN THE QUALITY AND INTEGRITY OF CLINICAL AND BASIC SCIENTIFIC RESEARCH IN THE FIELD OF GYNECOLOGIC MALIGNANCIES, INCLUDING CANCERS THAT ARISE FROM THE OVARIES, UTERUS, CERVIX, VAGINA, AND VULVA. OUR INSTITUTIONS AND INVESTIGATORS ARE ESSENTIAL CONTRIBUTORS TO ADVANCEMENTS IN TREATMENT REGIMENS, SURGICAL PROCEDURES, QUALITY OF LIFE ANALYSES, AND PREVENTION KNOWLEDGE. THE RESULTS OF GOG FOUNDATION CLINICAL TRIALS HAVE INFLUENCED THE STANDARD OF CARE FOR NUMEROUS MALIGNANT GYNECOLOGIC NEOPLASMS. THE MISSION OF THE GOG FOUNDATION IS TO CONDUCT CLINICAL AND TRANSLATIONAL RESEARCH THAT POSITIVELY IMPACTS WOMEN THROUGH THE PREVENTION AND TREATMENT OF GYNECOLOGIC MALIGNANCIES. THE VISION OF THE GOG FOUNDATION IS TO BE THE PREMIER COLLABORATIVE NETWORK FOR TRANSFORMATIVE RESEARCH IN GYNECOLOGIC MALIGNANCIES. 0 0 50465967 543825 44774881 THE FOUNDATION IS COMMITTED TO MAINTAINING THE HIGHEST STANDARDS IN CLINICAL TRIALS DEVELOPMENT, EXECUTION, ANALYSIS AND DISTRIBUTION OF RESULTS. CONTINUOUS EVALUATION OF OUR PROCESSES IS UTILIZED IN ORDER TO CONSTANTLY IMPROVE THE QUALITY OF PATIENT CARE. IN 2020 THE GOG FOUNDATION, INC. CONDUCTED CLINICAL TRIALS THROUGH OUR 300 PLUS INSTITUTIONS. THESE EXPENSES INCLUDED PROTOCOL DEVELOPMENT, REGULATORY AFFAIRS, MEETINGS TO REVIEW TRIAL DATA, TRIAL DEVELOPMENT THROUGH COMMITTEE FUNCTIONS AND OTHER INDIRECT RELATED EXPENSES. 50465967 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 45 0 1 41 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 11 10 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 MD X MARY C SHARP CFO 4107217126 3168 BRAVERTON ST NO 280 EDGEWATER MD 21037 X MARY C SHARP CHIEF FINANCIAL OFFICER 35.00 X 289934 0 60917 MICHAEL POWERS GENERAL COUNSEL 35.00 X 275368 0 42947 LAURA REESE EXECUTIVE DIRECTOR 35.00 X 258371 0 58562 DENISE MACKEY DIRECTOR OF ADMINISTRATION 35.00 X 180477 0 46809 LISA RICHFORD CONTRACTS ATTORNEY 35.00 X 141559 0 60256 JOSH KILLION DIRECTOR, INFORMATION TECHNOLOGY 35.00 X 157871 0 32265 HEATHER LANKES DIRECTOR, TRANSLATIONAL SCIENCE 35.00 X 158114 0 30823 KATHLEEN CAMPBELL-SIMMS DIRECTOR, SITE MANAGEMENT 35.00 X 134463 0 49474 LARRY J COPELAND MD PRESIDENT 20.00 X X 100000 0 0 ROBERT S MANNEL MD VICE PRESIDENT 13.00 X X 33333 0 0 THOMAS J HERZOG MD TREASURER 1.00 X X 0 0 0 DAVID G MUTCH MD SECRETARY 1.00 X X 0 0 0 ANGELES ALVAREZ SECORD MD DIRECTOR 1.00 X 0 0 0 ROBERT BURGER MD DIRECTOR (TO APR '21) 1.00 X 0 0 0 ROBERT L COLEMAN MD DIRECTOR 1.00 X 0 0 0 PAUL A DISILVESTRO MD DIRECTOR 1.00 X 0 0 0 BRADLEY J MONK MD DIRECTOR 1.00 X 0 0 0 KATHLEEN N MOORE MD DIRECTOR 1.00 X 0 0 0 LESLIE M RANDALL MD DIRECTOR 1.00 X 0 0 0 1729490 0 382053 16 0 1 0 DR LARRY J COPELAND MD 320 W 10TH AVE COLUMBUS OH 43210 CONSULTING SERVICES 150800 DR ROBERT COLEMAN MD 9180 PINECROFT DR STE 600 THE WOODLANDS TX 77380 CONSULTING SERVICES 141200 JENNIFER KLEIN 2000 ASHBURTOIN WY MOUNT PLEASANT SC 29466 CONSULTING SERVICES 109219 3 2931017 333400 3264417 INDUSTRY REVENUE 900099 44747888 44747888 REGISTRATION FEES 900099 26993 26993 44774881 2084113 4013 2080100 45128238 44122787 1005451 1005451 1005451 4954 4954 4954 51133816 44774881 4013 3090505 543825 543825 1028404 629316 348571 50517 3498783 2127698 1183388 187697 524381 283761 211326 29294 513655 299155 166262 48238 295316 182603 94160 18553 624917 576650 48267 117384 117384 1078895 759232 319663 2095 2095 243975 87546 155601 828 184654 4770 179884 281376 203680 77696 123381 93609 24579 5193 181385 160365 10409 10611 270462 270462 PURCHASE SERVICE AGREEM 35329272 35329272 CONSORTIUMS 5051215 5051215 HONORARIA 85864 85864 OVERHEAD ALLOCATION 0 3997273 -3997273 382975 50133 348854 -16012 50362214 50465967 -438672 334919 961 4461 12143180 18554894 1014059 755334 36172 36572 0 103709 67635588 68885379 2108139 7654141 731256 802251 55018 54589 83724373 96851330 725285 5450476 10851217 14911272 11576502 20361748 X 72147871 76489582 72147871 76489582 83724373 96851330 771602 3570109 0 X 0 1 X 1 1 1 X 5236856 5135505 3475111 2990743 3264417 20102632 5236856 5135505 3475111 2990743 3264417 20102632 20102632 1132952 1486285 1558710 2026706 2080100 8284753 85776 37116 115076 21845 0 259813 11412 23997 48680 4954 89043 28736241 141375815 0.69960 0.74930 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 ALTERNATIVE INVESTMENTS 7654141 C 7654141 X 54703925 3570109 3570109 51133816 0 51133816 50362214 0 50362214 0 50362214 PART X, LINE 2: MANAGEMENT HAS CONCLUDED THAT GOG FOUNDATION HAS PROPERLY MAINTAINED ITS EXEMPT STATUS, AND THERE ARE NO UNCERTAIN TAX POSITIONS AS OF DECEMBER 31, 2020 OR 2019. CENTRAL AMERICA AND THE CARIBBEAN 0 0 INVESTMENTS 6899000 0 0 0 0 0 0 6899000 0 6899000 1 0 1 0 1 0 PART III ACCOUNTING METHOD: 1 AMERICAN ASSOCIATION OF OBSTETRICIANS AND GYNECOLOGISTS FOUNDATION 2331 ROCK SPRING RD FOREST HILL MD 21050 386042799 501(3) 188825 GENERAL SUPPORT UNIVERSITY OF MISSOURI - ST LOUIS 1 UNIVERSITY BLVD SAINT LOUIS MO 63121 266440629 115(A) 150000 RSDP GRANT WASHINGTON UNIVERSITY 700 ROSEDALE AVENUE CB 1034 SAINT LOUIS MO 63112 430653611 501(3) 125000 RSDP GRANT SOCIETY OF GYNECOLOGIC ONCOLOGY 230 W MONROE ST STE 710 CHICAGO IL 60606 611657046 501(6) 50000 SGO FLY IN DAY INTERNATIONAL GYNECOLOGIC CANCER SOCIETY 9100 SHELBYVILLE RD STE 200 LOUISVILLE KY 40222 753269205 501(3) 30000 GENERAL SUPPORT 4 1 PART I, LINE 2: THE GOG FOUNDATION SELECTS ORGANIZATIONS FOR GRANTS THAT FURTHER THE EXEMPT PURPOSE OF THE GOG FOUNDATION. THE RECIPIENTS OF THESE GRANTS ARE EXEMPT ORGANIZATIONS WITH MISSIONS CONGRUOUS WITH THOSE OF THE GOG FOUNDATION. X X 0 0 0 0 0 0 0 0 0 MARY C SHARP CHIEF FINANCIAL OFFICER 264819 0 6790 0 18325 0 43828 0 17089 0 350851 0 0 0 MICHAEL POWERS GENERAL COUNSEL 249254 0 6391 0 19723 0 41308 0 1639 0 318315 0 0 0 LAURA REESE EXECUTIVE DIRECTOR 235045 0 6027 0 17299 0 39067 0 19495 0 316933 0 0 0 DENISE MACKEY DIRECTOR OF ADMINISTRATION 159348 0 4928 0 16201 0 27383 0 19426 0 227286 0 0 0 LISA RICHFORD CONTRACTS ATTORNEY 124887 0 3863 0 12809 0 21894 0 38362 0 201815 0 0 0 JOSH KILLION DIRECTOR, INFORMATION TECHNOLOGY 129128 0 8117 0 20626 0 23835 0 8430 0 190136 0 0 0 HEATHER LANKES DIRECTOR, TRANSLATIONAL SCIENCE 137200 0 4243 0 16671 0 23855 0 6968 0 188937 0 0 0 KATHLEEN CAMPBELL-SIMMS DIRECTOR, SITE MANAGEMENT 117212 0 3625 0 13626 0 20672 0 28802 0 183937 0 0 0 DR LARRY J COPELAND MD PRESIDENT 150800 CONSULTING SERVICES 0 FORM 990, PART VI, SECTION B, LINE 11B FORM 990 IS REVIEWED BY THE CFO BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C CONFLICT OF INTEREST DISCLOSURE FORMS ARE REVIEWED ANNUALLY BY THE FOUNDATION CHAIR, AND ON AN INTERIM BASIS. THE FOUNDATION CHAIR REVIEWS ANNUAL FORMS NO LATER THAN NOVEMBER 1 OF EACH YEAR, AND INTERIM FORMS WITHIN 30 DAYS. THE CONFLICT IS MANAGED, REDUCED, OR ELIMINATED, AT LEAST ON AN INTERIM BASIS, WITHIN 60 DAYS OF ITS IDENTIFICATION. FORM 990, PART VI, SECTION B, LINE 15 OFFICER AND KEY EMPLOYEE SALARY IS APPROVED BY THE CEO AND TREASURER ANNUALLY, IN CONSULTATION WITH A COMPENSATION SURVEY WHICH IS OBTAINED PERIODICALLY. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, POLICIES, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE AT RECEPTIONIST'S DESK. FORM 990, PART VII, SECTION A: DR. MANNEL'S EMPLOYER, THE UNIVERSITY OF OKLAHOMA, WAS COMPENSATED $33,333 FOR DR. MANNEL'S SERVICES TO THE BOARD.